These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 16286015

  • 1. Human TLR-7-, -8-, and -9-mediated induction of IFN-alpha/beta and -lambda Is IRAK-4 dependent and redundant for protective immunity to viruses.
    Yang K, Puel A, Zhang S, Eidenschenk C, Ku CL, Casrouge A, Picard C, von Bernuth H, Senechal B, Plancoulaine S, Al-Hajjar S, Al-Ghonaium A, Maródi L, Davidson D, Speert D, Roifman C, Garty BZ, Ozinsky A, Barrat FJ, Coffman RL, Miller RL, Li X, Lebon P, Rodriguez-Gallego C, Chapel H, Geissmann F, Jouanguy E, Casanova JL.
    Immunity; 2005 Nov; 23(5):465-78. PubMed ID: 16286015
    [Abstract] [Full Text] [Related]

  • 2. Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses.
    Zhang SY, Jouanguy E, Sancho-Shimizu V, von Bernuth H, Yang K, Abel L, Picard C, Puel A, Casanova JL.
    Immunol Rev; 2007 Dec; 220(1):225-36. PubMed ID: 17979850
    [Abstract] [Full Text] [Related]

  • 3. Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response.
    Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G.
    Nature; 2006 Jan 12; 439(7073):208-11. PubMed ID: 16306936
    [Abstract] [Full Text] [Related]

  • 4. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR, Brown D, Bonilla FA, Geha RS.
    J Allergy Clin Immunol; 2006 Dec 12; 118(6):1357-62. PubMed ID: 17157666
    [Abstract] [Full Text] [Related]

  • 5. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.
    Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Maródi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL.
    J Exp Med; 2007 Oct 01; 204(10):2407-22. PubMed ID: 17893200
    [Abstract] [Full Text] [Related]

  • 6. TLR activation pathways in HIV-1-exposed seronegative individuals.
    Biasin M, Piacentini L, Lo Caputo S, Naddeo V, Pierotti P, Borelli M, Trabattoni D, Mazzotta F, Shearer GM, Clerici M.
    J Immunol; 2010 Mar 01; 184(5):2710-7. PubMed ID: 20124101
    [Abstract] [Full Text] [Related]

  • 7. Chemokine, cytokine and type I interferon production induced by Toll-like receptor activation in common variable immune deficiency.
    Lollo C, de Moraes Vasconcelos D, Oliveira LMDS, Domingues R, Carvalho GC, Duarte AJDS, Sato MN.
    Clin Immunol; 2016 Aug 01; 169():121-127. PubMed ID: 27392462
    [Abstract] [Full Text] [Related]

  • 8. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation.
    Gujer C, Sundling C, Seder RA, Karlsson Hedestam GB, Loré K.
    Immunology; 2011 Nov 01; 134(3):257-69. PubMed ID: 21977996
    [Abstract] [Full Text] [Related]

  • 9. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
    Gotoh K, Tanaka Y, Nishikimi A, Nakamura R, Yamada H, Maeda N, Ishikawa T, Hoshino K, Uruno T, Cao Q, Higashi S, Kawaguchi Y, Enjoji M, Takayanagi R, Kaisho T, Yoshikai Y, Fukui Y.
    J Exp Med; 2010 Apr 12; 207(4):721-30. PubMed ID: 20231379
    [Abstract] [Full Text] [Related]

  • 10. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.
    Paradowska-Gorycka A, Wajda A, Stypinska B, Walczuk E, Rzeszotarska E, Walczyk M, Haladyj E, Romanowska-Prochnicka K, Felis-Giemza A, Lewandowska A, Olesińska M.
    Clin Exp Immunol; 2021 Apr 12; 204(1):49-63. PubMed ID: 33336388
    [Abstract] [Full Text] [Related]

  • 11. Inherited human IRAK-1 deficiency selectively impairs TLR signaling in fibroblasts.
    Della Mina E, Borghesi A, Zhou H, Bougarn S, Boughorbel S, Israel L, Meloni I, Chrabieh M, Ling Y, Itan Y, Renieri A, Mazzucchelli I, Basso S, Pavone P, Falsaperla R, Ciccone R, Cerbo RM, Stronati M, Picard C, Zuffardi O, Abel L, Chaussabel D, Marr N, Li X, Casanova JL, Puel A.
    Proc Natl Acad Sci U S A; 2017 Jan 24; 114(4):E514-E523. PubMed ID: 28069966
    [Abstract] [Full Text] [Related]

  • 12. Induction and regulation of IFNs during viral infections.
    Malmgaard L.
    J Interferon Cytokine Res; 2004 Aug 24; 24(8):439-54. PubMed ID: 15320958
    [Abstract] [Full Text] [Related]

  • 13. Toll-like receptor 7 and 9 defects in common variable immunodeficiency.
    Yu JE, Knight AK, Radigan L, Marron TU, Zhang L, Sanchez-Ramón S, Cunningham-Rundles C.
    J Allergy Clin Immunol; 2009 Aug 24; 124(2):349-56, 356.e1-3. PubMed ID: 19592080
    [Abstract] [Full Text] [Related]

  • 14. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
    Sirén J, Pirhonen J, Julkunen I, Matikainen S.
    J Immunol; 2005 Feb 15; 174(4):1932-7. PubMed ID: 15699120
    [Abstract] [Full Text] [Related]

  • 15. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S.
    J Exp Med; 2005 Mar 21; 201(6):915-23. PubMed ID: 15767370
    [Abstract] [Full Text] [Related]

  • 16. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma.
    Huen AO, Rook AH.
    Curr Opin Oncol; 2014 Mar 21; 26(2):237-44. PubMed ID: 24441505
    [Abstract] [Full Text] [Related]

  • 17. [Toll-like receptors that sense viral infection].
    Seya T, Shingai M, Matsumoto M.
    Uirusu; 2004 Jun 21; 54(1):1-8. PubMed ID: 15449898
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human interleukin-1 receptor-associated kinase-2 is essential for Toll-like receptor-mediated transcriptional and post-transcriptional regulation of tumor necrosis factor alpha.
    Flannery SM, Keating SE, Szymak J, Bowie AG.
    J Biol Chem; 2011 Jul 08; 286(27):23688-97. PubMed ID: 21606490
    [Abstract] [Full Text] [Related]

  • 20. CL097, a TLR7/8 ligand, inhibits TLR-4--dependent activation of IRAK-M and BCL-3 expression.
    Petricevic B, Wessner B, Sachet M, Vrbanec D, Spittler A, Bergmann M.
    Shock; 2009 Nov 08; 32(5):484-90. PubMed ID: 19333135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.